MMI (Medical Microinstruments, Inc.), a robotics company dedicated to expanding treatment options and improving outcomes for patients with complex conditions, today announced completion of the first ...
Founded in 2015, MMI said it is developing robotic technology that pushes the limits of soft tissue open surgery.
Introduction Only symptomatic treatments are available for patients with Parkinson’s disease (PD), the second most common chronic neurodegenerative disease worldwide, and it is therefore imperative to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback